[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Genomic Biomarkers Market Size, Status and Forecast 2020-2026

May 2020 | 96 pages | ID: G7A1BCEDAB8FEN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report focuses on the global Genomic Biomarkers status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Genomic Biomarkers development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
  • Thermo Fisher Scientific
  • Roche
  • Aepodia
  • Myriad Genetics
  • Eurofins Scientific
  • QIAGEN
  • Bio-Rad Laboratories
  • Genomic Health
  • Liquid Genomics
  • Epigenomics
  • AROS Applied Biotechnology
Market segment by Type, the product can be split into
  • Oncology
  • Cardiovascular diseases
  • Neurological diseases
  • Others
Market segment by Application, split into
  • Diagnostic and research laboratories
  • Hospitals
  • Others
Market segment by Regions/Countries, this report covers
  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
  • Central & South America
The study objectives of this report are:
  • To analyze global Genomic Biomarkers status, future forecast, growth opportunity, key market and key players.
  • To present the Genomic Biomarkers development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
  • To strategically profile the key players and comprehensively analyze their development plan and strategies.
  • To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Genomic Biomarkers are as follows:
  • History Year: 2015-2019
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Genomic Biomarkers Revenue
1.4 Market Analysis by Type
  1.4.1 Global Genomic Biomarkers Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Oncology
  1.4.3 Cardiovascular diseases
  1.4.4 Neurological diseases
  1.4.5 Others
1.5 Market by Application
  1.5.1 Global Genomic Biomarkers Market Share by Application: 2020 VS 2026
  1.5.2 Diagnostic and research laboratories
  1.5.3 Hospitals
  1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Genomic Biomarkers Market Perspective (2015-2026)
2.2 Genomic Biomarkers Growth Trends by Regions
  2.2.1 Genomic Biomarkers Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Genomic Biomarkers Historic Market Share by Regions (2015-2020)
  2.2.3 Genomic Biomarkers Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Genomic Biomarkers Market Growth Strategy
  2.3.6 Primary Interviews with Key Genomic Biomarkers Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Genomic Biomarkers Players by Market Size
  3.1.1 Global Top Genomic Biomarkers Players by Revenue (2015-2020)
  3.1.2 Global Genomic Biomarkers Revenue Market Share by Players (2015-2020)
  3.1.3 Global Genomic Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Genomic Biomarkers Market Concentration Ratio
  3.2.1 Global Genomic Biomarkers Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Genomic Biomarkers Revenue in 2019
3.3 Genomic Biomarkers Key Players Head office and Area Served
3.4 Key Players Genomic Biomarkers Product Solution and Service
3.5 Date of Enter into Genomic Biomarkers Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Genomic Biomarkers Historic Market Size by Type (2015-2020)
4.2 Global Genomic Biomarkers Forecasted Market Size by Type (2021-2026)

5 GENOMIC BIOMARKERS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Genomic Biomarkers Market Size by Application (2015-2020)
5.2 Global Genomic Biomarkers Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Genomic Biomarkers Market Size (2015-2020)
6.2 Genomic Biomarkers Key Players in North America (2019-2020)
6.3 North America Genomic Biomarkers Market Size by Type (2015-2020)
6.4 North America Genomic Biomarkers Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Genomic Biomarkers Market Size (2015-2020)
7.2 Genomic Biomarkers Key Players in Europe (2019-2020)
7.3 Europe Genomic Biomarkers Market Size by Type (2015-2020)
7.4 Europe Genomic Biomarkers Market Size by Application (2015-2020)

8 CHINA

8.1 China Genomic Biomarkers Market Size (2015-2020)
8.2 Genomic Biomarkers Key Players in China (2019-2020)
8.3 China Genomic Biomarkers Market Size by Type (2015-2020)
8.4 China Genomic Biomarkers Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Genomic Biomarkers Market Size (2015-2020)
9.2 Genomic Biomarkers Key Players in Japan (2019-2020)
9.3 Japan Genomic Biomarkers Market Size by Type (2015-2020)
9.4 Japan Genomic Biomarkers Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Genomic Biomarkers Market Size (2015-2020)
10.2 Genomic Biomarkers Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Genomic Biomarkers Market Size by Type (2015-2020)
10.4 Southeast Asia Genomic Biomarkers Market Size by Application (2015-2020)

11 INDIA

11.1 India Genomic Biomarkers Market Size (2015-2020)
11.2 Genomic Biomarkers Key Players in India (2019-2020)
11.3 India Genomic Biomarkers Market Size by Type (2015-2020)
11.4 India Genomic Biomarkers Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Genomic Biomarkers Market Size (2015-2020)
12.2 Genomic Biomarkers Key Players in Central & South America (2019-2020)
12.3 Central & South America Genomic Biomarkers Market Size by Type (2015-2020)
12.4 Central & South America Genomic Biomarkers Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Thermo Fisher Scientific
  13.1.1 Thermo Fisher Scientific Company Details
  13.1.2 Thermo Fisher Scientific Business Overview and Its Total Revenue
  13.1.3 Thermo Fisher Scientific Genomic Biomarkers Introduction
  13.1.4 Thermo Fisher Scientific Revenue in Genomic Biomarkers Business (2015-2020))
  13.1.5 Thermo Fisher Scientific Recent Development
13.2 Roche
  13.2.1 Roche Company Details
  13.2.2 Roche Business Overview and Its Total Revenue
  13.2.3 Roche Genomic Biomarkers Introduction
  13.2.4 Roche Revenue in Genomic Biomarkers Business (2015-2020)
  13.2.5 Roche Recent Development
13.3 Aepodia
  13.3.1 Aepodia Company Details
  13.3.2 Aepodia Business Overview and Its Total Revenue
  13.3.3 Aepodia Genomic Biomarkers Introduction
  13.3.4 Aepodia Revenue in Genomic Biomarkers Business (2015-2020)
  13.3.5 Aepodia Recent Development
13.4 Myriad Genetics
  13.4.1 Myriad Genetics Company Details
  13.4.2 Myriad Genetics Business Overview and Its Total Revenue
  13.4.3 Myriad Genetics Genomic Biomarkers Introduction
  13.4.4 Myriad Genetics Revenue in Genomic Biomarkers Business (2015-2020)
  13.4.5 Myriad Genetics Recent Development
13.5 Eurofins Scientific
  13.5.1 Eurofins Scientific Company Details
  13.5.2 Eurofins Scientific Business Overview and Its Total Revenue
  13.5.3 Eurofins Scientific Genomic Biomarkers Introduction
  13.5.4 Eurofins Scientific Revenue in Genomic Biomarkers Business (2015-2020)
  13.5.5 Eurofins Scientific Recent Development
13.6 QIAGEN
  13.6.1 QIAGEN Company Details
  13.6.2 QIAGEN Business Overview and Its Total Revenue
  13.6.3 QIAGEN Genomic Biomarkers Introduction
  13.6.4 QIAGEN Revenue in Genomic Biomarkers Business (2015-2020)
  13.6.5 QIAGEN Recent Development
13.7 Bio-Rad Laboratories
  13.7.1 Bio-Rad Laboratories Company Details
  13.7.2 Bio-Rad Laboratories Business Overview and Its Total Revenue
  13.7.3 Bio-Rad Laboratories Genomic Biomarkers Introduction
  13.7.4 Bio-Rad Laboratories Revenue in Genomic Biomarkers Business (2015-2020)
  13.7.5 Bio-Rad Laboratories Recent Development
13.8 Genomic Health
  13.8.1 Genomic Health Company Details
  13.8.2 Genomic Health Business Overview and Its Total Revenue
  13.8.3 Genomic Health Genomic Biomarkers Introduction
  13.8.4 Genomic Health Revenue in Genomic Biomarkers Business (2015-2020)
  13.8.5 Genomic Health Recent Development
13.9 Liquid Genomics
  13.9.1 Liquid Genomics Company Details
  13.9.2 Liquid Genomics Business Overview and Its Total Revenue
  13.9.3 Liquid Genomics Genomic Biomarkers Introduction
  13.9.4 Liquid Genomics Revenue in Genomic Biomarkers Business (2015-2020)
  13.9.5 Liquid Genomics Recent Development
13.10 Epigenomics
  13.10.1 Epigenomics Company Details
  13.10.2 Epigenomics Business Overview and Its Total Revenue
  13.10.3 Epigenomics Genomic Biomarkers Introduction
  13.10.4 Epigenomics Revenue in Genomic Biomarkers Business (2015-2020)
  13.10.5 Epigenomics Recent Development
13.11 AROS Applied Biotechnology
  10.11.1 AROS Applied Biotechnology Company Details
  10.11.2 AROS Applied Biotechnology Business Overview and Its Total Revenue
  10.11.3 AROS Applied Biotechnology Genomic Biomarkers Introduction
  10.11.4 AROS Applied Biotechnology Revenue in Genomic Biomarkers Business (2015-2020)
  10.11.5 AROS Applied Biotechnology Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES

Table 1. Genomic Biomarkers Key Market Segments
Table 2. Key Players Covered: Ranking by Genomic Biomarkers Revenue
Table 3. Ranking of Global Top Genomic Biomarkers Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Genomic Biomarkers Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Oncology
Table 6. Key Players of Cardiovascular diseases
Table 7. Key Players of Neurological diseases
Table 8. Key Players of Others
Table 9. Global Genomic Biomarkers Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Genomic Biomarkers Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Genomic Biomarkers Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Genomic Biomarkers Market Share by Regions (2015-2020)
Table 13. Global Genomic Biomarkers Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Genomic Biomarkers Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Genomic Biomarkers Market Growth Strategy
Table 19. Main Points Interviewed from Key Genomic Biomarkers Players
Table 20. Global Genomic Biomarkers Revenue by Players (2015-2020) (Million US$)
Table 21. Global Genomic Biomarkers Market Share by Players (2015-2020)
Table 22. Global Top Genomic Biomarkers Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genomic Biomarkers as of 2019)
Table 23. Global Genomic Biomarkers by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Genomic Biomarkers Product Solution and Service
Table 26. Date of Enter into Genomic Biomarkers Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Genomic Biomarkers Market Size by Type (2015-2020) (Million US$)
Table 29. Global Genomic Biomarkers Market Size Share by Type (2015-2020)
Table 30. Global Genomic Biomarkers Revenue Market Share by Type (2021-2026)
Table 31. Global Genomic Biomarkers Market Size Share by Application (2015-2020)
Table 32. Global Genomic Biomarkers Market Size by Application (2015-2020) (Million US$)
Table 33. Global Genomic Biomarkers Market Size Share by Application (2021-2026)
Table 34. North America Key Players Genomic Biomarkers Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Genomic Biomarkers Market Share (2019-2020)
Table 36. North America Genomic Biomarkers Market Size by Type (2015-2020) (Million US$)
Table 37. North America Genomic Biomarkers Market Share by Type (2015-2020)
Table 38. North America Genomic Biomarkers Market Size by Application (2015-2020) (Million US$)
Table 39. North America Genomic Biomarkers Market Share by Application (2015-2020)
Table 40. Europe Key Players Genomic Biomarkers Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Genomic Biomarkers Market Share (2019-2020)
Table 42. Europe Genomic Biomarkers Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Genomic Biomarkers Market Share by Type (2015-2020)
Table 44. Europe Genomic Biomarkers Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Genomic Biomarkers Market Share by Application (2015-2020)
Table 46. China Key Players Genomic Biomarkers Revenue (2019-2020) (Million US$)
Table 47. China Key Players Genomic Biomarkers Market Share (2019-2020)
Table 48. China Genomic Biomarkers Market Size by Type (2015-2020) (Million US$)
Table 49. China Genomic Biomarkers Market Share by Type (2015-2020)
Table 50. China Genomic Biomarkers Market Size by Application (2015-2020) (Million US$)
Table 51. China Genomic Biomarkers Market Share by Application (2015-2020)
Table 52. Japan Key Players Genomic Biomarkers Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Genomic Biomarkers Market Share (2019-2020)
Table 54. Japan Genomic Biomarkers Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Genomic Biomarkers Market Share by Type (2015-2020)
Table 56. Japan Genomic Biomarkers Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Genomic Biomarkers Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Genomic Biomarkers Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Genomic Biomarkers Market Share (2019-2020)
Table 60. Southeast Asia Genomic Biomarkers Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Genomic Biomarkers Market Share by Type (2015-2020)
Table 62. Southeast Asia Genomic Biomarkers Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Genomic Biomarkers Market Share by Application (2015-2020)
Table 64. India Key Players Genomic Biomarkers Revenue (2019-2020) (Million US$)
Table 65. India Key Players Genomic Biomarkers Market Share (2019-2020)
Table 66. India Genomic Biomarkers Market Size by Type (2015-2020) (Million US$)
Table 67. India Genomic Biomarkers Market Share by Type (2015-2020)
Table 68. India Genomic Biomarkers Market Size by Application (2015-2020) (Million US$)
Table 69. India Genomic Biomarkers Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Genomic Biomarkers Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Genomic Biomarkers Market Share (2019-2020)
Table 72. Central & South America Genomic Biomarkers Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Genomic Biomarkers Market Share by Type (2015-2020)
Table 74. Central & South America Genomic Biomarkers Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Genomic Biomarkers Market Share by Application (2015-2020)
Table 76. Thermo Fisher Scientific Company Details
Table 77. Thermo Fisher Scientific Business Overview
Table 78. Thermo Fisher Scientific Product
Table 79. Thermo Fisher Scientific Revenue in Genomic Biomarkers Business (2015-2020) (Million US$)
Table 80. Thermo Fisher Scientific Recent Development
Table 81. Roche Company Details
Table 82. Roche Business Overview
Table 83. Roche Product
Table 84. Roche Revenue in Genomic Biomarkers Business (2015-2020) (Million US$)
Table 85. Roche Recent Development
Table 86. Aepodia Company Details
Table 87. Aepodia Business Overview
Table 88. Aepodia Product
Table 89. Aepodia Revenue in Genomic Biomarkers Business (2015-2020) (Million US$)
Table 90. Aepodia Recent Development
Table 91. Myriad Genetics Company Details
Table 92. Myriad Genetics Business Overview
Table 93. Myriad Genetics Product
Table 94. Myriad Genetics Revenue in Genomic Biomarkers Business (2015-2020) (Million US$)
Table 95. Myriad Genetics Recent Development
Table 96. Eurofins Scientific Company Details
Table 97. Eurofins Scientific Business Overview
Table 98. Eurofins Scientific Product
Table 99. Eurofins Scientific Revenue in Genomic Biomarkers Business (2015-2020) (Million US$)
Table 100. Eurofins Scientific Recent Development
Table 101. QIAGEN Company Details
Table 102. QIAGEN Business Overview
Table 103. QIAGEN Product
Table 104. QIAGEN Revenue in Genomic Biomarkers Business (2015-2020) (Million US$)
Table 105. QIAGEN Recent Development
Table 106. Bio-Rad Laboratories Company Details
Table 107. Bio-Rad Laboratories Business Overview
Table 108. Bio-Rad Laboratories Product
Table 109. Bio-Rad Laboratories Revenue in Genomic Biomarkers Business (2015-2020) (Million US$)
Table 110. Bio-Rad Laboratories Recent Development
Table 111. Genomic Health Business Overview
Table 112. Genomic Health Product
Table 113. Genomic Health Company Details
Table 114. Genomic Health Revenue in Genomic Biomarkers Business (2015-2020) (Million US$)
Table 115. Genomic Health Recent Development
Table 116. Liquid Genomics Company Details
Table 117. Liquid Genomics Business Overview
Table 118. Liquid Genomics Product
Table 119. Liquid Genomics Revenue in Genomic Biomarkers Business (2015-2020) (Million US$)
Table 120. Liquid Genomics Recent Development
Table 121. Epigenomics Company Details
Table 122. Epigenomics Business Overview
Table 123. Epigenomics Product
Table 124. Epigenomics Revenue in Genomic Biomarkers Business (2015-2020) (Million US$)
Table 125. Epigenomics Recent Development
Table 126. AROS Applied Biotechnology Company Details
Table 127. AROS Applied Biotechnology Business Overview
Table 128. AROS Applied Biotechnology Product
Table 129. AROS Applied Biotechnology Revenue in Genomic Biomarkers Business (2015-2020) (Million US$)
Table 130. AROS Applied Biotechnology Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Global Genomic Biomarkers Market Share by Type: 2020 VS 2026
Figure 2. Oncology Features
Figure 3. Cardiovascular diseases Features
Figure 4. Neurological diseases Features
Figure 5. Others Features
Figure 6. Global Genomic Biomarkers Market Share by Application: 2020 VS 2026
Figure 7. Diagnostic and research laboratories Case Studies
Figure 8. Hospitals Case Studies
Figure 9. Others Case Studies
Figure 10. Genomic Biomarkers Report Years Considered
Figure 11. Global Genomic Biomarkers Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Genomic Biomarkers Market Share by Regions: 2020 VS 2026
Figure 13. Global Genomic Biomarkers Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Genomic Biomarkers Market Share by Players in 2019
Figure 16. Global Top Genomic Biomarkers Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genomic Biomarkers as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Genomic Biomarkers Revenue in 2019
Figure 18. North America Genomic Biomarkers Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Genomic Biomarkers Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Genomic Biomarkers Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Genomic Biomarkers Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Genomic Biomarkers Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Genomic Biomarkers Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Genomic Biomarkers Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Thermo Fisher Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Thermo Fisher Scientific Revenue Growth Rate in Genomic Biomarkers Business (2015-2020)
Figure 27. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Roche Revenue Growth Rate in Genomic Biomarkers Business (2015-2020)
Figure 29. Aepodia Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Aepodia Revenue Growth Rate in Genomic Biomarkers Business (2015-2020)
Figure 31. Myriad Genetics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Myriad Genetics Revenue Growth Rate in Genomic Biomarkers Business (2015-2020)
Figure 33. Eurofins Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Eurofins Scientific Revenue Growth Rate in Genomic Biomarkers Business (2015-2020)
Figure 35. QIAGEN Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. QIAGEN Revenue Growth Rate in Genomic Biomarkers Business (2015-2020)
Figure 37. Bio-Rad Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Bio-Rad Laboratories Revenue Growth Rate in Genomic Biomarkers Business (2015-2020)
Figure 39. Genomic Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Genomic Health Revenue Growth Rate in Genomic Biomarkers Business (2015-2020)
Figure 41. Liquid Genomics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Liquid Genomics Revenue Growth Rate in Genomic Biomarkers Business (2015-2020)
Figure 43. Epigenomics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Epigenomics Revenue Growth Rate in Genomic Biomarkers Business (2015-2020)
Figure 45. AROS Applied Biotechnology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. AROS Applied Biotechnology Revenue Growth Rate in Genomic Biomarkers Business (2015-2020)
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed


More Publications